103 related articles for article (PubMed ID: 31678748)
1. Frequency of arterial thromboembolism in populations with malignancies: A systematic review.
Yu J; Li A; Laureano M; Crowther M
Thromb Res; 2019 Dec; 184():16-23. PubMed ID: 31678748
[TBL] [Abstract][Full Text] [Related]
2. Incidence and Risk of Various Types of Arterial Thromboembolism in Patients With Cancer.
Wang J; Kim YD; Kim CH
Mayo Clin Proc; 2021 Mar; 96(3):592-600. PubMed ID: 33673912
[TBL] [Abstract][Full Text] [Related]
3. Risk of Arterial Thromboembolism in Patients With Cancer.
Navi BB; Reiner AS; Kamel H; Iadecola C; Okin PM; Elkind MSV; Panageas KS; DeAngelis LM
J Am Coll Cardiol; 2017 Aug; 70(8):926-938. PubMed ID: 28818202
[TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.
Khorana AA; Dalal M; Lin J; Connolly GC
Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of arterial thromboembolism in older men with breast cancer.
Reiner AS; Navi BB; DeAngelis LM; Panageas KS
Breast Cancer Res Treat; 2017 Dec; 166(3):903-910. PubMed ID: 28836029
[TBL] [Abstract][Full Text] [Related]
6. Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New Research.
Langouo Fontsa M; Aiello MM; Migliori E; Scartozzi M; Lambertini M; Willard-Gallo K; Solinas C
Target Oncol; 2022 Sep; 17(5):497-505. PubMed ID: 36102923
[TBL] [Abstract][Full Text] [Related]
7. Incidence, Risk Factors, and Outcomes of Arterial Thromboembolism in Patients with Pancreatic Cancer Following Palliative Chemotherapy.
Hung YS; Chen JS; Chen YY; Lu CH; Chang PH; Chou WC
Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30424491
[TBL] [Abstract][Full Text] [Related]
8. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study.
Mahmoodi BK; Brouwer JL; Veeger NJ; van der Meer J
Circulation; 2008 Oct; 118(16):1659-67. PubMed ID: 18824642
[TBL] [Abstract][Full Text] [Related]
9. Venous and Lung Thromboembolism in the Context of Lung Cancer: Clinical Manifestations, Risk Factors and Prognosis.
Maia R; Neves I; Morais A; Queiroga H
Acta Med Port; 2019 Oct; 32(10):647-653. PubMed ID: 31625877
[TBL] [Abstract][Full Text] [Related]
10. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
11. Relation of Venous Thromboembolism Risk to Ischemic Stroke Risk in Hospitalized Patients with Cancer.
Corley AM; Sullivan MJ; Friedman SE; O'Rourke DJ; Palac RT; Gemignani AS
Am J Cardiol; 2019 Feb; 123(4):679-683. PubMed ID: 30528279
[TBL] [Abstract][Full Text] [Related]
12. Thromboprophylaxis for inpatients with advanced cancer in palliative care settings: A systematic review and narrative synthesis.
Cai R; Zimmermann C; Krzyzanowska M; Granton J; Hannon B
Palliat Med; 2019 May; 33(5):486-499. PubMed ID: 30819046
[TBL] [Abstract][Full Text] [Related]
13. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study.
Mahmoodi BK; ten Kate MK; Waanders F; Veeger NJ; Brouwer JL; Vogt L; Navis G; van der Meer J
Circulation; 2008 Jan; 117(2):224-30. PubMed ID: 18158362
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
Ferroni P; Riondino S; Formica V; Cereda V; Tosetto L; La Farina F; Valente MG; Vergati M; Guadagni F; Roselli M
Int J Cancer; 2015 Mar; 136(5):1234-40. PubMed ID: 25042739
[TBL] [Abstract][Full Text] [Related]
15. Tumor Genomic Profile Is Associated With Arterial Thromboembolism Risk in Patients With Solid Cancer.
Feldman S; Gupta D; Navi BB; Grace Ho KW; Willeit P; Devlin S; Bolton KL; Arcila ME; Mantha S
JACC CardioOncol; 2023 Apr; 5(2):246-255. PubMed ID: 37144118
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
[TBL] [Abstract][Full Text] [Related]
17. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
[TBL] [Abstract][Full Text] [Related]
18. Statin use and venous thromboembolism in cancer: A large, active comparator, propensity score matched cohort study.
El-Refai SM; Black EP; Adams VR; Talbert JC; Brown JD
Thromb Res; 2017 Oct; 158():49-58. PubMed ID: 28822240
[TBL] [Abstract][Full Text] [Related]
19. Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study.
Brand JS; Hedayati E; Bhoo-Pathy N; Bergh J; Hall P; Humphreys K; Ludvigsson JF; Czene K
Cancer; 2017 Feb; 123(3):468-475. PubMed ID: 27727456
[TBL] [Abstract][Full Text] [Related]
20. Venous thrombosis and risk of cancer in patients with arterial cardiovascular disease.
Schmidt SA; Farkas DK; Pedersen L; Prandoni P; Sørensen HT
Thromb Res; 2015 Jan; 135(1):96-101. PubMed ID: 25467083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
